|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
178 a.a.
|
 |
|
|
|
|
|
|
|
185 a.a.
|
 |
|
|
|
|
|
|
|
16 a.a.
|
 |
|
|
|
|
|
|
|
178 a.a.
|
 |
|
|
|
|
* Residue conservation analysis
|
|
|
|
|
PDB id:
|
 |
|
 |
| Name: |
 |
Immune system
|
 |
|
Title:
|
 |
Crystal structure of the human cd4 n-terminal two domain fragment complexed to a class ii mhc molecule
|
|
Structure:
|
 |
H-2 class ii histocompatibility antigen, a-k alpha chain. Chain: a. Engineered: yes. H-2 class ii histocompatibility antigen, a-k beta chain. Chain: b. Engineered: yes. Ovotransferrin. Chain: c. Synonym: conalbumin.
|
|
Source:
|
 |
Mus musculus. House mouse. Organism_taxid: 10090. Expressed in: cricetulus griseus. Expression_system_taxid: 10029. Gallus gallus. Chicken. Organism_taxid: 9031. Expressed in: gallus gallus.
|
|
Biol. unit:
|
 |
Tetramer (from
)
|
|
Resolution:
|
 |
|
4.30Å
|
R-factor:
|
0.428
|
R-free:
|
0.453
|
|
|
Authors:
|
 |
J.-H.Wang,R.Meijers,E.L.Reinherz
|
Key ref:
|
 |
J.H.Wang
et al.
(2001).
Crystal structure of the human CD4 N-terminal two-domain fragment complexed to a class II MHC molecule.
Proc Natl Acad Sci U S A,
98,
10799-10804.
PubMed id:
DOI:
|
 |
|
Date:
|
 |
|
15-Jul-01
|
Release date:
|
19-Sep-01
|
|
|
|
|
|
PROCHECK
|
|
|
|
|
Headers
|
 |
|
|
References
|
|
|
|
|
|
|
P01910
(HA2K_MOUSE) -
H-2 class II histocompatibility antigen, A-K alpha chain from Mus musculus
|
|
|
|
Seq: Struc:
|
 |
 |
 |
256 a.a.
178 a.a.
|
|
|
|
|
|
|
|
|
 |
 |
|
|
|
|
P06343
(HB2K_MOUSE) -
H-2 class II histocompatibility antigen, A-K beta chain from Mus musculus
|
|
|
|
Seq: Struc:
|
 |
 |
 |
263 a.a.
185 a.a.*
|
|
|
|
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
DOI no:
|
Proc Natl Acad Sci U S A
98:10799-10804
(2001)
|
|
PubMed id:
|
|
|
|
|
| |
|
Crystal structure of the human CD4 N-terminal two-domain fragment complexed to a class II MHC molecule.
|
|
J.H.Wang,
R.Meijers,
Y.Xiong,
J.H.Liu,
T.Sakihama,
R.Zhang,
A.Joachimiak,
E.L.Reinherz.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
The structural basis of the interaction between the CD4 coreceptor and a class
II major histocompatibility complex (MHC) is described. The crystal structure of
a complex containing the human CD4 N-terminal two-domain fragment and the murine
I-A(k) class II MHC molecule with associated peptide (pMHCII) shows that only
the "top corner" of the CD4 molecule directly contacts pMHCII. The CD4
Phe-43 side chain extends into a hydrophobic concavity formed by MHC residues
from both alpha 2 and beta 2 domains. A ternary model of the CD4-pMHCII-T-cell
receptor (TCR) reveals that the complex appears V-shaped with the
membrane-proximal pMHCII at the apex. This configuration excludes a direct
TCR-CD4 interaction and suggests how TCR and CD4 signaling is coordinated around
the antigenic pMHCII complex. Human CD4 binds to HIV gp120 in a manner
strikingly similar to the way in which CD4 interacts with pMHCII. Additional
contacts between gp120 and CD4 give the CD4-gp120 complex a greater affinity.
Thus, ligation of the viral envelope glycoprotein to CD4 occludes the
pMHCII-binding site on CD4, contributing to immunodeficiency.
|
|
|
|
|
| |
Selected figure(s)
|
|
|
| |
 |
 |
|
 |
|
 |
Figure 1.
Fig. 1. Ribbon diagram of the CD4-pMHCII complex. The
murine I-A^k MHC class II molecule with a CA peptide (green)
bound to the antigen-presenting platform interacts with hCD4
(cyan) through both the 2 (red) and
the 2 (yellow)
domains of pMHCII and domain 1 (D1) of hCD4. Residues Lys-35,
Phe-43, Lys-46, and Arg-59 on CD4 D1 essential for binding are
highlighted. The CD loop (delineated with an arrow) on the 2 domain of
the I-A^k molecule is shown to have no direct interactions with
CD4. Note also how CD4 D2 (unlabeled, cyan) makes no contact to
pMHCII. All the figures were prepared with MOLSCRIPT (46) and
RASTER 3D (47).
|
 |
Figure 4.
Fig. 4. Molecular mimicry of gp120 binding to CD4
relative to MHC class II. (A) The CD4 D1D2-gp120 complex (ref.
42, with Fab not included for clarity) is shown in similar
orientation to the complex of CD4 D1D2/I-A^k in Fig. 1. The
interactions that are in common are displayed in the box, which
shows the Phe-43 inserted in a hydrophobic pocket involving
gp120 15 and 23, the
formation of an antiparallel mini- -sheet
between the C" strand of CD4 and 15 from
gp120 as well as interactions between CD4 Arg-59 and the loop
connecting 20 to 21 in gp120.
Besides these core interactions, gp120 has additional contacts
through the V1/V2 loop connecting the 2 and 3 strands,
the D loop,
and the V5 loop. (B) Overlay of CD4-CA/I-A^k and CD4-gp120 (42)
complexes based on hCD4 D1 (blue and pink, respectively) with
I-A^k in yellow and gp120 in red. Phe-43 and Arg-59 side chains
are shown.
|
 |
|
|
| |
Figures were
selected
by an automated process.
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
A.O.Tarakanov,
and
K.G.Fuxe
(2010).
Triplet puzzle: homologies of receptor heteromers.
|
| |
J Mol Neurosci,
41,
294-303.
|
 |
|
|
|
|
 |
J.J.Tan,
X.J.Cong,
L.M.Hu,
C.X.Wang,
L.Jia,
and
X.J.Liang
(2010).
Therapeutic strategies underpinning the development of novel techniques for the treatment of HIV infection.
|
| |
Drug Discov Today,
15,
186-197.
|
 |
|
|
|
|
 |
M.M.Freeman,
M.S.Seaman,
S.Rits-Volloch,
X.Hong,
C.Y.Kao,
D.D.Ho,
and
B.Chen
(2010).
Crystal structure of HIV-1 primary receptor CD4 in complex with a potent antiviral antibody.
|
| |
Structure,
18,
1632-1641.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
R.Song,
D.Franco,
C.Y.Kao,
F.Yu,
Y.Huang,
and
D.D.Ho
(2010).
Epitope mapping of ibalizumab, a humanized Anti-CD4 monoclonal antibody with anti-HIV-1 activity in infected patients.
|
| |
J Virol,
84,
6935-6942.
|
 |
|
|
|
|
 |
C.Brorsson,
N.T.Hansen,
K.Lage,
R.Bergholdt,
S.Brunak,
and
F.Pociot
(2009).
Identification of T1D susceptibility genes within the MHC region by combining protein interaction networks and SNP genotyping data.
|
| |
Diabetes Obes Metab,
11,
60-66.
|
 |
|
|
|
|
 |
H.R.Haghighi,
L.R.Read,
S.M.Haeryfar,
S.Behboudi,
and
S.Sharif
(2009).
Identification of a dual-specific T cell epitope of the hemagglutinin antigen of an h5 avian influenza virus in chickens.
|
| |
PLoS One,
4,
e7772.
|
 |
|
|
|
|
 |
J.D.Stone,
A.S.Chervin,
and
D.M.Kranz
(2009).
T-cell receptor binding affinities and kinetics: impact on T-cell activity and specificity.
|
| |
Immunology,
126,
165-176.
|
 |
|
|
|
|
 |
L.Wooldridge,
A.Lissina,
D.K.Cole,
H.A.van den Berg,
D.A.Price,
and
A.K.Sewell
(2009).
Tricks with tetramers: how to get the most from multimeric peptide-MHC.
|
| |
Immunology,
126,
147-164.
|
 |
|
|
|
|
 |
Y.Chen,
Y.Shi,
H.Cheng,
Y.Q.An,
and
G.F.Gao
(2009).
Structural immunology and crystallography help immunologists see the immune system in action: how T and NK cells touch their ligands.
|
| |
IUBMB Life,
61,
579-590.
|
 |
|
|
|
|
 |
Y.Xiao,
A.M.Lazaro,
C.Masaberg,
M.Haagenson,
C.Vierra-Green,
S.Spellman,
S.Dakshanamurthy,
J.Ng,
and
C.K.Hurley
(2009).
Evaluating the potential impact of mismatches outside the antigen recognition site in unrelated hematopoietic stem cell transplantation: HLA-DRB1*1454 and DRB1*140101.
|
| |
Tissue Antigens,
73,
595-598.
|
 |
|
|
|
|
 |
J.D.Silk,
M.Salio,
J.Brown,
E.Y.Jones,
and
V.Cerundolo
(2008).
Structural and functional aspects of lipid binding by CD1 molecules.
|
| |
Annu Rev Cell Dev Biol,
24,
369-395.
|
 |
|
|
|
|
 |
N.Korotkova,
Y.Yang,
I.Le Trong,
E.Cota,
B.Demeler,
J.Marchant,
W.E.Thomas,
R.E.Stenkamp,
S.L.Moseley,
and
S.Matthews
(2008).
Binding of Dr adhesins of Escherichia coli to carcinoembryonic antigen triggers receptor dissociation.
|
| |
Mol Microbiol,
67,
420-434.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
N.R.Gascoigne
(2008).
Do T cells need endogenous peptides for activation?
|
| |
Nat Rev Immunol,
8,
895-900.
|
 |
|
|
|
|
 |
R.Burri,
H.N.Hirzel,
N.Salamin,
A.Roulin,
and
L.Fumagalli
(2008).
Evolutionary patterns of MHC class II B in owls and their implications for the understanding of avian MHC evolution.
|
| |
Mol Biol Evol,
25,
1180-1191.
|
 |
|
|
|
|
 |
R.Burri,
H.Niculita-Hirzel,
A.Roulin,
and
L.Fumagalli
(2008).
Isolation and characterization of major histocompatibility complex (MHC) class II B genes in the Barn owl (Aves: Tyto alba).
|
| |
Immunogenetics,
60,
543-550.
|
 |
|
|
|
|
 |
Z.D.Zhang,
G.Weinstock,
and
M.Gerstein
(2008).
Rapid evolution by positive Darwinian selection in T-cell antigen CD4 in primates.
|
| |
J Mol Evol,
66,
446-456.
|
 |
|
|
|
|
 |
A.Thedrez,
C.de Lalla,
S.Allain,
L.Zaccagnino,
S.Sidobre,
C.Garavaglia,
G.Borsellino,
P.Dellabona,
M.Bonneville,
E.Scotet,
and
G.Casorati
(2007).
CD4 engagement by CD1d potentiates activation of CD4+ invariant NKT cells.
|
| |
Blood,
110,
251-258.
|
 |
|
|
|
|
 |
E.Gostick,
D.K.Cole,
S.L.Hutchinson,
L.Wooldridge,
S.Tafuro,
B.Laugel,
A.Lissina,
A.Oxenius,
J.M.Boulter,
D.A.Price,
and
A.K.Sewell
(2007).
Functional and biophysical characterization of an HLA-A*6801-restricted HIV-specific T cell receptor.
|
| |
Eur J Immunol,
37,
479-486.
|
 |
|
|
|
|
 |
G.P.Bondinas,
A.K.Moustakas,
and
G.K.Papadopoulos
(2007).
The spectrum of HLA-DQ and HLA-DR alleles, 2006: a listing correlating sequence and structure with function.
|
| |
Immunogenetics,
59,
539-553.
|
 |
|
|
|
|
 |
J.S.Hauswaldt,
H.Stuckas,
S.Pfautsch,
and
R.Tiedemann
(2007).
Molecular characterization of MHC class II in a nonmodel anuran species, the fire-bellied toad Bombina bombina.
|
| |
Immunogenetics,
59,
479-491.
|
 |
|
|
|
|
 |
M.Krogsgaard,
J.Juang,
and
M.M.Davis
(2007).
A role for "self" in T-cell activation.
|
| |
Semin Immunol,
19,
236-244.
|
 |
|
|
|
|
 |
M.S.Kuhns,
and
M.M.Davis
(2007).
Disruption of extracellular interactions impairs T cell receptor-CD3 complex stability and signaling.
|
| |
Immunity,
26,
357-369.
|
 |
|
|
|
|
 |
A.T.Neffe,
M.Bilang,
and
B.Meyer
(2006).
Synthesis and optimization of peptidomimetics as HIV entry inhibitors against the receptor protein CD4 using STD NMR and ligand docking.
|
| |
Org Biomol Chem,
4,
3259-3267.
|
 |
|
|
|
|
 |
B.DeLaBarre,
and
A.T.Brunger
(2006).
Considerations for the refinement of low-resolution crystal structures.
|
| |
Acta Crystallogr D Biol Crystallogr,
62,
923-932.
|
 |
|
|
|
|
 |
J.Vaynberg,
and
J.Qin
(2006).
Weak protein-protein interactions as probed by NMR spectroscopy.
|
| |
Trends Biotechnol,
24,
22-27.
|
 |
|
|
|
|
 |
L.Wooldridge,
T.J.Scriba,
A.Milicic,
B.Laugel,
E.Gostick,
D.A.Price,
R.E.Phillips,
and
A.K.Sewell
(2006).
Anti-coreceptor antibodies profoundly affect staining with peptide-MHC class I and class II tetramers.
|
| |
Eur J Immunol,
36,
1847-1855.
|
 |
|
|
|
|
 |
M.G.Rudolph,
R.L.Stanfield,
and
I.A.Wilson
(2006).
How TCRs bind MHCs, peptides, and coreceptors.
|
| |
Annu Rev Immunol,
24,
419-466.
|
 |
|
|
|
|
 |
B.Chen,
E.M.Vogan,
H.Gong,
J.J.Skehel,
D.C.Wiley,
and
S.C.Harrison
(2005).
Determining the structure of an unliganded and fully glycosylated SIV gp120 envelope glycoprotein.
|
| |
Structure,
13,
197-211.
|
 |
|
|
|
|
 |
H.C.Chang,
K.Tan,
J.Ouyang,
E.Parisini,
J.H.Liu,
Y.Le,
X.Wang,
E.L.Reinherz,
and
J.H.Wang
(2005).
Structural and mutational analyses of a CD8alphabeta heterodimer and comparison with the CD8alphaalpha homodimer.
|
| |
Immunity,
23,
661-671.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
H.C.Miller,
K.Belov,
and
C.H.Daugherty
(2005).
Characterization of MHC class II genes from an ancient reptile lineage, Sphenodon (tuatara).
|
| |
Immunogenetics,
57,
883-891.
|
 |
|
|
|
|
 |
J.Liu,
J.Ying,
V.T.Chow,
V.J.Hruby,
and
S.D.Satyanarayanajois
(2005).
Structure-activity studies of peptides from the "hot-spot" region of human CD2 protein: development of peptides for immunomodulation.
|
| |
J Med Chem,
48,
6236-6249.
|
 |
|
|
|
|
 |
M.Hahn,
M.J.Nicholson,
J.Pyrdol,
and
K.W.Wucherpfennig
(2005).
Unconventional topology of self peptide-major histocompatibility complex binding by a human autoimmune T cell receptor.
|
| |
Nat Immunol,
6,
490-496.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
N.R.Gascoigne,
and
T.Zal
(2004).
Molecular interactions at the T cell-antigen-presenting cell interface.
|
| |
Curr Opin Immunol,
16,
114-119.
|
 |
|
|
|
|
 |
O.P.Kristiansen,
A.E.Karlsen,
Z.M.Larsen,
J.Johannesen,
F.Pociot,
and
T.Mandrup-Poulsen
(2004).
Identification of a type 1 diabetes-associated CD4 promoter haplotype with high constitutive activity.
|
| |
Scand J Immunol,
59,
582-591.
|
 |
|
|
|
|
 |
Q.J.Li,
A.R.Dinner,
S.Qi,
D.J.Irvine,
J.B.Huppa,
M.M.Davis,
and
A.K.Chakraborty
(2004).
CD4 enhances T cell sensitivity to antigen by coordinating Lck accumulation at the immunological synapse.
|
| |
Nat Immunol,
5,
791-799.
|
 |
|
|
|
|
 |
Y.H.Sanejouand
(2004).
Domain swapping of CD4 upon dimerization.
|
| |
Proteins,
57,
205-212.
|
 |
|
|
|
|
 |
A.E.Prota,
J.A.Campbell,
P.Schelling,
J.C.Forrest,
M.J.Watson,
T.R.Peters,
M.Aurrand-Lions,
B.A.Imhof,
T.S.Dermody,
and
T.Stehle
(2003).
Crystal structure of human junctional adhesion molecule 1: implications for reovirus binding.
|
| |
Proc Natl Acad Sci U S A,
100,
5366-5371.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
A.J.Bankovich,
and
K.C.Garcia
(2003).
Not just any T cell receptor will do.
|
| |
Immunity,
18,
7.
|
 |
|
|
|
|
 |
A.Trautmann,
and
C.Randriamampita
(2003).
Initiation of TCR signalling revisited.
|
| |
Trends Immunol,
24,
425-428.
|
 |
|
|
|
|
 |
J.H.Wang,
and
M.J.Eck
(2003).
Assembling atomic resolution views of the immunological synapse.
|
| |
Curr Opin Immunol,
15,
286-293.
|
 |
|
|
|
|
 |
M.Krogsgaard,
J.B.Huppa,
M.A.Purbhoo,
and
M.M.Davis
(2003).
Linking molecular and cellular events in T-cell activation and synapse formation.
|
| |
Semin Immunol,
15,
307-315.
|
 |
|
|
|
|
 |
P.A.van der Merwe,
and
S.J.Davis
(2003).
Molecular interactions mediating T cell antigen recognition.
|
| |
Annu Rev Immunol,
21,
659-684.
|
 |
|
|
|
|
 |
R.N.Germain
(2003).
T-cell activation: the power of one.
|
| |
Curr Biol,
13,
R137-R139.
|
 |
|
|
|
|
 |
Y.Liu,
Y.Xiong,
O.V.Naidenko,
J.H.Liu,
R.Zhang,
A.Joachimiak,
M.Kronenberg,
H.Cheroutre,
E.L.Reinherz,
and
J.H.Wang
(2003).
The crystal structure of a TL/CD8alphaalpha complex at 2.1 A resolution: implications for modulation of T cell activation and memory.
|
| |
Immunity,
18,
205-215.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
D.J.Irvine,
M.A.Purbhoo,
M.Krogsgaard,
and
M.M.Davis
(2002).
Direct observation of ligand recognition by T cells.
|
| |
Nature,
419,
845-849.
|
 |
|
|
|
|
 |
G.F.Gao,
Z.Rao,
and
J.I.Bell
(2002).
Molecular coordination of alphabeta T-cell receptors and coreceptors CD8 and CD4 in their recognition of peptide-MHC ligands.
|
| |
Trends Immunol,
23,
408-413.
|
 |
|
|
|
|
 |
J.A.LaBonte,
G.J.Babcock,
T.Patel,
and
J.Sodroski
(2002).
Blockade of HIV-1 infection of New World monkey cells occurs primarily at the stage of virus entry.
|
| |
J Exp Med,
196,
431-445.
|
 |
|
|
|
|
 |
J.Wang
(2002).
Protein recognition by cell surface receptors: physiological receptors versus virus interactions.
|
| |
Trends Biochem Sci,
27,
122-126.
|
 |
|
|
|
|
 |
K.Tan,
B.D.Zelus,
R.Meijers,
J.H.Liu,
J.M.Bergelson,
N.Duke,
R.Zhang,
A.Joachimiak,
K.V.Holmes,
and
J.H.Wang
(2002).
Crystal structure of murine sCEACAM1a[1,4]: a coronavirus receptor in the CEA family.
|
| |
EMBO J,
21,
2076-2086.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
M.G.Rudolph,
and
I.A.Wilson
(2002).
The specificity of TCR/pMHC interaction.
|
| |
Curr Opin Immunol,
14,
52-65.
|
 |
|
|
|
|
 |
M.G.Rudolph,
J.G.Luz,
and
I.A.Wilson
(2002).
Structural and thermodynamic correlates of T cell signaling.
|
| |
Annu Rev Biophys Biomol Struct,
31,
121-149.
|
 |
|
|
|
|
 |
P.Drevot,
C.Langlet,
X.J.Guo,
A.M.Bernard,
O.Colard,
J.P.Chauvin,
R.Lasserre,
and
H.T.He
(2002).
TCR signal initiation machinery is pre-assembled and activated in a subset of membrane rafts.
|
| |
EMBO J,
21,
1899-1908.
|
 |
|
|
|
|
 |
R.König
(2002).
Interactions between MHC molecules and co-receptors of the TCR.
|
| |
Curr Opin Immunol,
14,
75-83.
|
 |
|
|
|
|
 |
J.Owens,
J.Milburn,
J.Clough,
B.Ramster,
N.Baderman,
and
R.Lawrence
(2001).
News in brief.
|
| |
Drug Discov Today,
6,
1083-1087.
|
 |
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
code is
shown on the right.
|
');
}
}
| |